OPK

OPKO Health Inc.

Price

$1.46

return (12m)

7.35%

p/e

-13.83

p/bv

0.85

DIVIDEND YIELD

0.00%

OPK price

OPKO Health

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OPK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

19.67%

3 months

14.06%

1 year

7.35%

2 years

-5.81%

5 years

-60.22%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals OPK

Valuation

P/E

-13.83

Sector -4.38

Industry -4.38

P/BV

0.85

Sector 2.02

Industry 2.02

P/Revenue (PSR)

1.71

Sector -4.40

Industry -4.40

EV/EBITDA

51.28

Sector -263.09

Industry -263.09

EV/EBIT

-517.65

Sector -702.90

Industry -702.90

P/EBITDA

18.37

Sector -4.39

Industry -4.39

P/EBIT

-28.93

Sector -4.73

Industry -4.73

P/Total Assets

0.55

Sector 1.49

Industry 1.49

P/Net Current Assets

-6.95

Sector -11.70

Industry -11.70

P/Working Capital

2.87

Sector -3.19

Industry -3.19

EPS

-0.10

Sector -2.14

Industry -2.14

BVPS

1.57

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

40.77%

Sector 36.74%

Industry 36.74%

EBITDA Margin

12.46%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-1.23%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-28.56%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-12.40%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.09

Sector 0.03

Industry 0.03

Profitability

ROE

-6.16%

Sector -65.14%

Industry -65.14%

ROA

-3.98%

Sector -65.53%

Industry -65.53%

ROIC

-4.39%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.35

Sector 2.90

Industry 2.90

Net Debt / EBITDA

1.85

Sector -6.07

Industry -6.07

Net Debt / EBIT

-18.68

Sector -8.26

Industry -8.26

Net Debt / Equity

0.03

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.29

Sector -0.05

Industry -0.05

Equity/Assets

0.65

Sector 0.41

Industry 0.41

Liabilities/Assets

0.35

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-19.83%

Sector -

Industry -

5Y Earnings CAGR

19.32%

Sector -

Industry -

Fundamentals OPK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OPK OPKO Health Inc.	$1.46	4.29%	0.00%	-13.83	0.85	-6.16%	-12.40%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OPK Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT OPKO Health

OPKO Health Inc.

Average Investor10 user rating

4.0 (0 people)

United States

35 years

Founded: 1991

1995

Time since IPO - 31 years

6.096

Employees

OPKO Health Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.01 billion, with shareholders equity totaling $1.18 billion.

The company employs approximately 6.096 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, OPKO Health Inc. reported $587.90 million in revenue, generating net income of $-72.90 million.

Key financial metrics include a P/E ratio of -13.83, a price-to-book (P/B) ratio of 0.85, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OPK.

Market cap

$1.01 billion

Net worth

$1.18 billion

$1,184,170,000.00

Assets

$1.83 billion

$1,829,450,000.00

Total Shares Outstanding

755.00 million

755,000,000

Average Daily Trading Volume

$3.66 million

$3,661,653.06

Sector

Health Care

Industry

Biotechnology

OPK

OPK revenue and profits

Financial Results OPK

DRAG THE FRAME TO SEE MORE DATA

OPK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of OPKO Health (OPK) today?

A cotação de OPKO Health (OPK) hoje está em US$ 1.46, com uma variação de 7.35% em relação ao último ano. A cotação de OPKO Health (OPK) iniciou o ano negociando na casa dos US$ 1.26 e hoje está em US$ 1.46. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de OPKO Health (OPK) e dados de ações do Ibovespa e mercados internacionais.

Quando OPKO Health (OPK) paga dividendos?

OPKO Health (OPK) não distribuiu dividendos no último ano.

Is OPKO Health (OPK) a good investment?

Atualmente, OPKO Health (OPK) está cotada a US$ 1.46, com um P/L de -13.83, representando um desvio de -916% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 7.35 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 7.35%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy OPKO Health (OPK) stock?

Investir em ações de OPKO Health (OPK) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of OPKO Health (OPK) yield today?

A rentabilidade de OPKO Health (OPK) foi de 19.67% no último mês, 7.35% no último ano e -60.22% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de OPKO Health (OPK) hoje, o investimento total seria de US$ 146.00, com base na cotação atual de US$ 1.46.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 156.73
Em 5 anos: US$ 58.08
Em 10 anos: US$ 146.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

OPK

OPKO Health Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment OPK

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING OPK WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT OPKO Health

OPKO Health Inc.

United States

35 years

1995

6.096

PROFIT X PRICE OPK

Financial Results OPK

OPK cash flow

Asset, Revenue and Profit Growth - OPK

OPK balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions